X‐ray investigations of bicyclic α‐methyl­ene‐δ‐valerolactones. III. trans‐(4aR,8aR)‐4a‐Methoxy‐3‐methyleneperhydro­chromen‐2‐one

The title compound, C₁₁H₁₆O₃, adopts a conformation in which the δ‐valerolactone and cyclo­hexane rings are almost coplanar with one another. The β‐methoxy substituent occupies an axial position with respect to the cyclo­hexane ring. The δ‐valerolactone moiety adopts a half‐chair arrangement, while the cyclo­hexane ring exists in a chair conformation.     

X‐ray investigations of bicyclic α‐methyl­ene‐δ‐valerolactones. II. (4aS,8aS)‐4a‐Methyl‐3‐methyl­eneper­hydro­chromen‐2‐one

The title compound, C₁₁H₁₆O₂, adopts a semifolded conformation with the δ‐lactone and cyclo­hexane rings almost perpendicular to one another. The β‐methyl substituent occupies an axial position with respect to the cyclo­hexane ring. The δ‐lactone moiety adopts a slightly distorted half‐chair arrangement, while the cyclo­hexane ring exists in an almost ideal chair conformation.     

16‐[3‐Methoxy‐4‐(2‐piperidin‐1‐yl­ethoxy)­benzyl­idene]‐17‐oxoandrost‐5‐en‐3β‐yl acetate monohydrate

The title compound, C₃₆H₄₉NO₅·H₂O, has the outer two six‐membered rings of the steroid nucleus in chair conformations. The central ring B of the steroid nucleus is in an 8β,9α‐half‐chair conformation, while ring D of the steroid adopts a slightly distorted 13β,14α‐half‐chair conformation. The piperidine ring is in a chair conformation. The methoxy­benzyl­idene moiety has an E configuration with respect to the carbonyl group at position 17. Intermolecular O—H?O and O—H?N hydrogen bonds link the steroid and water mol­ecules into chains which run parallel to the b axis.     

16‐(4‐Iso­propyl­benzyl­idene)­androst‐4‐ene‐3,17‐dione

In the title compound, C₂₉H₃₆O₂, the outer cyclohexene ring of the steroid nucleus has a conformation that lies about half‐way between a half‐chair and an envelope, while the central and outer cyclo­hexane rings of the steroid nucleus have slightly distorted chair conformations. The steroidal cyclo­pentane ring adopts a 13β,14α‐half‐chair conformation. The benzyl­idene moiety has an E configuration with respect to the carbonyl group on the cyclo­pentane ring. The dihedral angle between the mean planes of the steroid nucleus and the benzyl­idene moiety is 35.54 (9)°. The packing of the mol­ecules is assumed to be dictated mainly by weak intermolecular C—H⋯O interactions.     

18‐De­oxy‐13β,14‐dihydrolycoctam: the lycoctamone rearrangement confirmed

The structure of the title compound, C₂₃H₃₅NO₄, contains a unique penta­cyclic ring system wherein one cyclo­hexyl ring adopts a chair conformation, two cyclo­hexyl rings are in boat conformations, and a six‐membered heterocyclic ring and a cyclo­pentyl ring are in envelope conformations. The structures of the lycoctamones, α,β‐unsaturated aldehydes produced by acid‐catalyzed degradation of lactams of lycoctonine‐type alkaloids, previously deduced from the results of extensive chemical investigations have been proven to be correct by the determination of the crystal structure of this compound.     

24(R)‐Acetyl­oxy‐1α,2α‐epoxy­cholesta‐4,6‐dien‐3‐one hydrate

In the title compound, C₂₉H₄₂O₄·H₂O, cyclo­hexane rings A and B are in the sofa conformation, ring C is in a chair conformation and the five‐membered ring D is in an envelope conformation. The structure is stabilized by inter‐ and intramolecular C—H?O and O—H?O hydrogen bonds.     

(Z)‐2‐(3‐Hydroxy‐4‐methoxybenzylidene)‐1‐azabicyclo[2.2.2]octan‐3‐one

Crystals of the title compound, C₁₅H₁₇NO₃, were obtained from a condensation reaction of 3‐hydroxy‐4‐methoxy­benz­aldehyde with 1‐aza­bi­cyclo­[2.2.2]­octan‐3‐one and subsequent crystallization of the product from methanol. The title compound, containing a double bond that connects the aza­bicyclic ring system to the 3‐hydroxy‐4‐methoxy­benzyl­idene group, was obtained with Z geometry.     

1d‐3,4‐Di‐O‐(di­phenyl­methylphos­pho­nio)‐1,2,5,6‐tetra‐O‐methyl‐chiro‐inositol diiodide

The title compound, 3,4,5,6‐tetra­methoxy­cyclo­hexane‐1,2‐diyl­dioxy­bis­(methyl­di­phenyl­phospho­nium) diiodide, C₃₆­H₄₄­O₆­P₂²⁺·­2I^?, was prepared from a New Zealand natural product, d ‐chiro‐inositol, in order to develop new catalytic metal complexes. The inositol ring retains its usual chair conformation with only minor perturbations caused by the bound di­phenyl­methyl­phosphines. Crystal‐packing forces are provided by C—H?I cation–anion interactions.     

(1SR,2SR,3SR,4RS,5RS,6RS,7SR,8RS)‐7,8‐Dichloro­bicyclo­[4.2.0]octa‐2,3,4,5‐tetrayl tetra­acetate

In the title compound, C₁₆H₂₀Cl₂O₈, the bicyclic system contains a central non‐planar cyclo­hexane ring which is fused to a cyclo­butane moiety. The cyclo­hexane ring has a chair conformation and the whole system adopts a syn conformation. The structure provides information on the stereochemical course of the chlorination, photo‐oxidation and hydrox­ylation steps of the reaction.     

3,4‐(4‐Methoxy­benzo):8,9‐benzo­bicyclo­[4.4.1]­undeca‐3,8‐dien‐11‐one ethyl­ene acetal

The title compound, 5‐methoxy­spiro­[tetra­cyclo­[8.8.1.0^3,8.0^12,17]­nonadeca‐3,5,7,12,14,16‐hexene‐19,2′‐[1,3]­dioxolane], C₂₂H₂₄O₃, exhibits a twin‐chair conformation with the aromatic rings overlying each other. Comparison of the dihedral angle between these two rings with those from previously reported [3.3]­ortho­cyclo­phanes of this type suggests the presence of a weak attractive charge‐transfer interaction between the two, different, stacked arenes.     

16‐Cyano‐13α‐(5‐methyl‐1,3,4‐oxa­diazol‐2‐yl)‐13,16‐seco‐17‐nor­androst‐5‐en‐3β‐yl acetate

In the title compound, C₂₃H₃₁N₃O₃, the outer cyclo­hexane rings have chair conformations, while the central cyclohexene ring adopts a half‐chair conformation. In the solid state, intra‐ and intermolecular C—H⋯N interactions are observed.     

3‐(p‐Chloro­phenyl)‐4‐phenyl‐4,5‐di­hydro­isoxazole‐5‐spiro‐2′‐1′,2′,3′,4′‐tetra­hydro­naphthalen‐1′‐one

In the title compound, C₂₄H₁₈ClNO₂, the phenyl ring and the tetralone moiety are approximately orthogonal to the isoxazoline ring. The isoxazoline ring adopts an envelope conformation, while the cyclo­hexenone ring of the tetralone moiety has an intermediate sofa/half‐chair conformation. In this structure, one C—H?N intermolecular and two C—H?O intramolecular hydrogen bonds occur; the H?A distances are 2.60, and 2.35 and 2.57 Å, respectively. The mol­ecules are held together by an intermolecular C—H?N hydrogen bond, forming a one‐dimensional chain along the [100] direction.     

Methyl 4‐(2‐chloro‐5‐nitro­phenyl)‐2,7,7‐tri­methyl‐5‐oxo‐1,4,5,6,7,8‐hexa­hydro­quinoline‐3‐carboxyl­ate

The title compound, C₂₀H₂₁ClN₂O₅, has potential calcium modulatory properties. The 1,4‐di­hydro­pyridine ring has the usual shallow boat conformation. The 2‐chloro‐5‐nitro­phenyl ring is oriented such that the chloro substituent is in a synperiplanar orientation with respect to the 1,4‐di­hydro­pyridine ring plane, while the nitro substituent sits over the 1,4‐di­hydro­pyridine ring. The cyclo­hexenone ring has a conformation that is approximately half‐way between that of an envelope and that of a half‐chair. The mol­ecules are linked into chains by intermolecular N—H⋯O hydrogen bonds.     

3β‐(1‐Allyl‐1‐pyrrolidinio)‐16‐(2‐pyridylmethylene)androst‐5‐en‐17β‐ol bromide hemihydrate

The title compound, C₃₂H₄₅N₂O⁺·Br^?·0.5H₂O, has the outer two six‐membered rings in chair conformations, while the central ring is in an 8β,9α‐half‐chair conformation. The five‐mem­bered ring of the steroid nucleus adopts a slightly deformed 14α‐envelope conformation. The pyridyl­methyl­ene moiety has an E configuration with respect to the hydroxyl group at position 17. The structure is stabilized by a network of O—H?Br‐type intermolecular hydrogen bonds.     

4‐Ethoxycarbonyl‐3‐hydroxy‐3‐phenylcyclohexanone

The title compound, ethyl 2‐hydroxy‐4‐oxo‐2‐phenyl­cyclo­hexane­carboxyl­ate, C₁₅H₁₈O₄, was obtained by a Michael–Aldol condensation and has the cyclo­hexanone in a chair conformation. The attached hydroxy, ethoxy­carbonyl and phenyl groups are disposed in β‐axial, β‐equatorial and α‐­equatorial configurations, respectively. An intermolecular hydrogen bond, with an O?O distance of 2.874 (2) Å, links the OH group and the ring carbonyl. Weak intermolecular C—H?O=C (ester and ketone), O—H?O=C (ketone) and C—H?OH hydrogen bonds exist.     

16‐(4‐Cyanobenzylidene)‐3β‐pyrrolidinoandrost‐5‐en‐17β‐ol monohydrate

In the title compound, C₃₁H₄₀N₂O·H₂O, the outer two six‐membered rings are in chair conformations, while the central ring is in an 8β,9α‐half‐chair conformation. The five‐membered ring adopts a 13β‐envelope conformation and the cyano­benzyl­idene moiety has an E configuration with respect to the hydroxyl group at position 17. The steroid nuclei are linked by intermolecular O—H?O and O—H?N hydrogen bonds to form a molecular network. The molecular packing has an interesting feature, with the steroids aligned parallel to the b axis, forming a closed loop through hydrogen bonds linked via water mol­ecules.     

Rotenone α‐oxime

The structure determination of the title compound, rotenone α‐oxime [systematic name: 1,2,12,12a‐tetra­hydro‐8,9‐di­meth­oxy‐2‐(1‐methyl­ethenyl)‐[1]­benzo­py­rano­[3,4‐b]­furo­[2,3‐h][1]benzo­pyran‐6(6H)‐one oxime], C₂₃H₂₃NO₆, confirms that the mol­ecule has an approximately V‐shaped structure. One of the rings has a typical cyclo­hexene‐like monoplanar conformation and the central ring adopts a 1,2‐diplanar conformation.     

7,7‐Di­chloro‐1,6‐di­methyl‐2‐oxa‐5‐thia­bi­cyclo­[4.1.0]­heptane 5,5‐dioxide and 6‐chloro‐2,3‐di­hydro‐7‐methyl‐5‐methyl­ene‐2H,3H,5H‐1,4‐dithiepine 1,1,4,4‐tetraoxide

The structures of a 2‐oxa‐5‐thia­bi­cyclo­[4.1.0]­heptane derivative, C₇H₁₀Cl₂O₃S, (I), and a 2H,3H,5H‐1,4‐dithiepine derivative, C₇H₉ClO₄S₂, (II), are reported. The six‐membered ring in (I) has an envelope conformation and the seven‐membered ring in (II) adopts a chair conformation. There are no untoward intermolecular interactions in (I), but two Cl atoms make a short intermolecular contact across an inversion centre in (II), with a Cl?Cl distance of 3.2784 (9) Å, some 0.22 Å less than the sum of the van der Waals radii.     

Two isomers of 2,4‐di­benzyl‐8‐azabicyclo­[3.2.1]­octan‐3‐ol

The crystal structures of the title compounds, 2α,4α‐di­benzyl‐3α‐tropanol (2α,4α‐di­benzyl‐8‐methyl‐8‐aza­bi­cyclo­[3.2.1]­octan‐3α‐ol), C₂₂H₂₇NO, (I), and 2α,4α‐di­benzyl‐3β‐tropanol (2α,4α‐di­benzyl‐8‐methyl‐8‐aza­bi­cyclo­[3.2.1]­octan‐3β‐ol), C₂₂H₂₇NO, (II), show that both compounds have a piperidine ring in a chair conformation and a pyrrolidine ring in an envelope conformation. Isomer (I) is asymmetric, the benzyl groups having different orientations, whereas isomer (II) is mirror symmetric, and the N and O atoms, the C atom attached to the hydroxy group, and the methyl C atom attached to the N atom lie on the mirror plane. In the crystal structures of both (I) and (II), the mol­ecules are linked together by intermolecular O—H⋯N hydrogen bonds to form chains that run parallel to the a direction in (I) and parallel to b in (II).     

(4R,4aR,6S,7S,7aS)‐6‐Hydro­xy‐7‐hy­droxy­methyl‐4‐methyl­per­hydro­cyclo­penta­[c]­pyran‐1‐one chloro­form solvate from Valeriana laxiflora

The structure of an iridolactone isolated from Valeriana laxiflora was established as (4R,4aR,6S,7S,7aS)‐6‐hydroxy‐7‐hydroxy­methyl‐4‐methyl­per­hydro­cyclo­penta­[c]­pyran‐1‐one chloro­form solvate, C₁₀H₁₆O₄·CHCl₃. The two rings are cis‐fused. The δ‐lactone ring adopts a slightly twisted half‐chair conformation with approximate planarity of the lactone group and the cyclo­pentane ring adopts an envelope conformation. The hydroxy group, the hydroxymethyl group and the methyl group all have β orientations. The absolute configuration was determined using anomalous dispersion data enhanced by the adventitious inclusion of a chloro­form solvent mol­ecule. Hydro­gen bonding, crystal packing and ring conformations are discussed in detail.